Millie
your market intelligence analyst
Search Results
Edit Save
391 results
DiabetesNews 12/03/2019 12:24
There have been conflicting findings on the diabetes drug metformin’s possible relationship to cancer. The majority of studies conducted on metformin or other glucose-lowering medications and their effect on cancer risk have found inconclusive results, but some research suggests metformin may have a beneficial role in certain types of cancer. Read more.
DiabetesNews 12/01/2019 13:14
The physical damage to the body caused by diabetes, and concern about growing rates of diabetes in children and teens, are widely discussed. But there are also some serious psychological effects to consider, and whether these are addressed might make the difference in whether someone is successful in managing their diabetes or not. Read more.
DiabetesNews 11/30/2019 13:07
A drug used to treat breast cancer, neratinib, has the potential to stop the immune system from destroying beta cells in type 1 diabetes, according to German researchers. The researchers found that Neratinib was able to protect the beta cells, which produce insulin in the pancreas, enabling the beta cells to continue to produce insulin. […]
DiabetesNews 11/22/2019 00:38
In recent years, there have been warnings for the use of SGLT-2 Inhibitors that suggest an increased risk of fracture, particularly when placed on one SGLT2 inhibitor, canagliflozin (Invokana). In 2015, the US FDA added a warning on canagliflozin, indicating that patients on canagliflozin must use caution because of a fracture risk associated with the […]
DiabetesNews 11/15/2019 12:28
The TTT-1 trial will begin in Scotland early in 2020 to assess a new combination therapy using insulin, dapagliflozin, and semaglutide. It is being led by Dr John Petrie from the University of Glasgow, a leading expert in the treatment of type 1 diabetes. The trial hopes the treatment will become a new option for […]
DiabetesNews 11/15/2019 01:34
The circadian clocks inside the body’s cells that help regulate timing of many body functions and control cardiovascular disease risks within a 24-hour day appear to be affected by high glucose in obesity. “We know that high glucose impairs circadian clock functions, but now we want to know [if] by fixing the clock can we […]
DiabetesNews 11/14/2019 18:26
The World Health Organization (WHO) has announced a plan to lower the “overly expensive” price of insulin. The agency, which is part of the United Nations, wants other drug companies to produce generic versions of insulin, which it will then test. Since its discovery in 1923, the price of insulin has risen in the United […]
DiabetesNews 11/10/2019 18:36
Qternmet XR is a single, once daily oral tablet made of dapagliflozin, saxagliptin, and metformin. Results show that the combination of dapagliflozin and saxagliptin have improved glycemic outcomes when added to metformin in patients with diabetes as compared to either drug alone added to metformin. Adverse effects are similar to those of the individual medications. […]
DiabetesNews 11/07/2019 18:09
To save patients with a severe form of type 1 diabetes, pancreatic cell transplantation is a “last resort” treatment, because the process is long and complex, and many of the grafted cells die quickly. Researchers have found that adding amniotic epithelial cells to these cell clusters creates much more robust “super-islets” of Langerhans. Once transplanted, […]
DiabetesNews 11/04/2019 12:00
Researchers may be only beginning to understand how Alzheimer’s disease and type 2 diabetes could be linked. Deciphering the connection could lead to earlier Alzheimer’s diagnosis and better treatments for both diseases. The connection involves how the brain metabolizes blood sugar and the factors that influence that process, including diet, sleep, and cardiovascular health. […]
DiabetesNews 11/02/2019 12:11
Oral semaglutide, brand name Rybelsus, is the first GLP-1 agonist that can be taken by mouth rather than requiring an injection. Studies have shown a significant reduction in A1c, a reduction in cardiovascular disease, and a reduction in weight, without the risk of hypoglycemia, for this drug. Patients must carefully follow instructions for taking the […]

Agribusiness Economics

Business Issues

Companies - Public

Companies - Venture Funded

Agricultural Equipment

Chemicals - Agricultural

Chemicals - Industrial

Commodity Prices

Farm Financial Services

Farming, Forestry, Fisheries

Financial Results

Food and Human Nutrition

Global Markets

Global Risk Factors

Government Agencies

Information Technologies

Legal and Regulatory

Political Entities

Products - Animal

Products - Forest

Products - Plant

Seeds

Strategic Scenarios

Sources

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications